Zobrazeno 1 - 10
of 15
pro vyhledávání: '"63"'
Autor:
Jianhua Liu, Yang Li, Chenxi Liu, Fengchun Zhang, Jiayu Dai, Xiaobo Yu, Ziyan Wu, Wenjie Zheng, Liujun Tang, Linlin Cheng, Yongzhe Li, Liubing Li
Publikováno v:
BMC Immunology
BMC Immunology, Vol 22, Iss 1, Pp 1-17 (2021)
BMC Immunology, Vol 22, Iss 1, Pp 1-17 (2021)
Background Behcet’s disease (BD) is a relapsing systemic vascular autoimmune/inflammatory disease. Despite much effort to investigate BD, there are virtually no unique laboratory markers identified to help in the diagnosis of BD, and the pathogenes
Autor:
John Mo, Giorgia Grosso, Per-Johan Jakobsson, Elisabet Svenungsson, Kerstin Elvin, Iva Gunnarsson, Azita Sohrabian, Janne Lehtiö, Lennart Truedsson, Marika Kvarnström, Johan Rönnelid, Helena Idborg, Ann Sofi Sandberg, Peter Nilsson, Arash Zandian, Bo Nilsson
Publikováno v:
Arthritis Research & Therapy
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-11 (2019)
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-11 (2019)
Background Previous studies and own clinical observations of patients with systemic lupus erythematosus (SLE) suggest that SLE harbors distinct immunophenotypes. This heterogeneity might result in differences in response to treatment in different sub
Autor:
Gerald Berthet, Elvira Cannizzaro, Raphael Leuvenink, Andreas Woerner, Walter Baer, Daniela Kaiser, Silke Schroeder, Florence Aeschlimann, Ulrich Heininger, Michael Hofer
Publikováno v:
Pediatric Rheumatology Online Journal
Pediatric rheumatology online journal, vol. 14, no. 1, pp. 34
Pediatric rheumatology online journal, vol. 14, no. 1, pp. 34
Background To analyze the clinical presentation and complications of varicella zoster virus (VZV) infection in children with rheumatic diseases treated with immunosuppressive medication such as biological disease-modifying antirheumatic drugs (bDMARD
Autor:
Joan T. Merrill, Erik Rasmussen, Donna Holloway, Jill P. Buyon, Daniel J. Wallace, John Ferbas, Wayne Tsuji, Blaire Cooke, Tsui Chern Cheah, Ellen M. Ginzler, Kameswara Rao V. Kuchimanchi, Michael H. Weisman, William Stohl, Shelley Sims Belouski, R. John Looney, Arunan Kaliyaperumal, Debra Zack
Publikováno v:
Arthritis Research & Therapy
Blisibimod is a potent B cell-activating factor (BAFF) antagonist that binds to both cell membrane-expressed and soluble BAFF. The goal of these first-in-human studies was to characterize the safety, tolerability, and pharmacokinetic and pharmacodyna
Publikováno v:
BMC Neurology; 15, no 8 (2015)
BMC Neurology
BMC Neurology
Background: Phosphorylcholine is one of the major epitopes of oxidised low density lipoprotein. Low levels of IgM antibodies against phosphorylcholine (anti-PC) are associated with development of myocardial infarction and stroke. It has been shown th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::620fb2c9e02a44bf8e80bbb774642b2d
http://lup.lub.lu.se/record/5186101/file/7889919
http://lup.lub.lu.se/record/5186101/file/7889919
Autor:
Miguel Calabuig, Giada De Palma, Marcela Susana Medina, Carmen Ribes-Koninckx, Yolanda Sanz, Ester Donat, Inmaculada Nadal
Publikováno v:
Digital.CSIC. Repositorio Institucional del CSIC
instname
BMC Microbiology
BMC Microbiology, Vol 10, Iss 1, p 63 (2010)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
instname
BMC Microbiology
BMC Microbiology, Vol 10, Iss 1, p 63 (2010)
CONICET Digital (CONICET)
Consejo Nacional de Investigaciones Científicas y Técnicas
instacron:CONICET
25 pages, 2 figures, 2 tables.-- Provisional PDF.
[Background] Coeliac disease is a chronic intestinal inflammatory disorder caused by an aberrant immune response to dietary gluten proteins in genetically predisposed individuals. Mucosal immune
[Background] Coeliac disease is a chronic intestinal inflammatory disorder caused by an aberrant immune response to dietary gluten proteins in genetically predisposed individuals. Mucosal immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee1b6ccc97b108cc45f6f2124c06a58e
http://hdl.handle.net/10261/22404
http://hdl.handle.net/10261/22404
Autor:
Eleni Aklillu, Alphonse Okwera, Jackson K. Mukonzo, Jasper Ogwal-Okeng, Deogratious Sebuwufu, Lars L. Gustafsson, Neoline Nakasujja, Henry Luzze, Paul Waako
Publikováno v:
BMC Infectious Diseases
BackgroundHIV infection, anti-tuberculosis and efavirenz therapy are associated with neuropsychological effects. We evaluated the influence of rifampicin cotreatment, efavirenz pharmacokinetics and pharmacogenetics on neuropsychiatric disorders in Ug
Autor:
Berit Feiring, Preben Aavitsland, Bernardo Rafael Guzmán Herrador, Marianne A. Riise Bergsaker, Katrine Borgen
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 12, Iss 1, p 63 (2012)
BMC Infectious Diseases, Vol 12, Iss 1, p 63 (2012)
Background During the 2009-2010 pandemic in Norway, 12 513 laboratory-confirmed cases of pandemic influenza A(H1N1)pdm09, were reported to the Norwegian Surveillance System for Communicable Diseases (MSIS). 2.2 million persons (45% of the population)
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 11, Iss 1, p 265 (2011)
BMC Infectious Diseases, Vol 11, Iss 1, p 265 (2011)
Background Relationship of hepatitis C virus (HCV) infection with an increased risk of cardiovascular disease (CVD) in HIV-infected patients remains controversial. We evaluated endothelial function and subclinical atherosclerosis in HIV-infected pati
Autor:
Tania Winzenberg, Flavia M. Cicuttini, D. Dore, Johanne Martel-Pelletier, Guangju Zhai, Changhai Ding, François Abram, Stephen Quinn, Jean-Pierre Pelletier, Graeme Jones, Ashleigh Martens
Publikováno v:
Arthritis Research & Therapy
Introduction Recent evidence suggests that bone marrow lesions (BMLs) play a pivotal role in knee osteoarthritis (OA). The aims of this study were to determine: 1) whether baseline BML presence and/or severity predict site-specific cartilage defect p